Market Overview

36 Stocks Moving In Friday's Mid-Day Session

Share:

Gainers

  • LMP Automotive Holdings, Inc. (NASDAQ: LMPX) shares climbed 46.7% to $32.63 on continued momentum after the company's President and CEO, Samer Tawfik, purchased $1.73 million worth of the company's shares.
  • Sarepta Therapeutics, Inc. (NASDAQ: SRPT) climbed 34.3% to $135.30 after the company announced it has received FDA approval for VYONDYS 53.
  • Cohen & Company Inc. (NYSE: COHN) rose 28.9% to $4.60.
  • Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX) shares gained 21.5% to $4.46.
  • AdaptHealth Corp. (NASDAQ: AHCO) rose 15.3% to $12.59.
  • scPharmaceuticals Inc. (NASDAQ: SCPH) gained 13.3% to $4.9983.
  • NantKwest, Inc. (NASDAQ: NK) rose 12.7% to $2.48.
  • TG Therapeutics, Inc. (NASDAQ: TGTX) rose 12.6% to $10.58.
  • ChromaDex Corporation (NASDAQ: CDXC) gained 12.1% to $4.4150.
  • Satsuma Pharmaceuticals, Inc. (NASDAQ: STSA) climbed 11.4% to $13.20.
  • iHeartMedia, Inc. (NASDAQ: IHRT) gained 10.6% to $16.10 following a Reuters report Liberty Media is seeking an increased stake in the company.
  • Banco BBVA Argentina S.A. (NYSE: BBAR) climbed 10.2% to $4.9350.
  • Borr Drilling Limited (NYSE: BORR) gained 9.5% to $7.86.
  • The Royal Bank of Scotland Group plc (NYSE: RBS) shares rose 9.5% to $6.74.
  • EchoStar Corporation (NASDAQ: SATS) climbed 9.3% to $42.96.
  • Pampa Energia S.A. (NYSE: PAM) rose 9.3% to $15.60.
  • DiaMedica Therapeutics Inc. (NASDAQ: DMAC) gained 9.1% to $3.71.
  • Barclays PLC (NYSE: BCS) rose 7.3% to $9.74.
  • Datadog Inc (NASDAQ: DDOG) rose 7% to $38.20 after the company announced a new integration with Microsoft Azure DevOps.
  • Lloyds Banking Group plc (NYSE: LYG) rose 6.4% to $3.4050.
  • National Grid plc (NYSE: NGG) shares rose 5.9% to $61.64.
  • Adobe Inc. (NASDAQ: ADBE) rose 5% to $320.74 after the company reported better-than-expected Q4 EPS and sales results.

 

Check out these big penny stock gainers and losers

Losers

  • Vince Holding Corp. (NYSE: VNCE) dropped 21.1% to $19.65 after the company reported downbeat Q3 sales.
  • Aquestive Therapeutics, Inc. (NASDAQ: AQST) shares tumbled 19.5% to $5.39 after the company announced it has priced its public offering of 7 million shares at $5 per share.
  • Stage Stores, Inc. (NYSE: SSI) dropped 18.7% to $5.25.
  • Gridsum Holding Inc. (NASDAQ: GSUM) fell 18.7% to $1.78.
  • Athenex, Inc. (NASDAQ: ATNX) dropped 16.4% to $14.18 as investors react negatively to data from the company's Phase 3 trial comparing oral paclitaxel with IV paclitaxel.
  • OncoSec Medical Incorporated (NASDAQ: ONCS) dipped 15.8% to $2.03 after the company reported interim data from KEYNOTE-890 study evaluating TAVO in combination with KEYTRUDA.
  • Transenterix Inc (NYSE: TRXC) dropped 15.1% to $1.91.
  • Good Times Restaurants Inc.. (NASDAQ: GTIM) fell 14.6% to $1.4090 after the company reported Q4 results.
  • Assembly Biosciences Inc (NASDAQ: ASMB) dipped 14% to $20.48.
  • Anixa Biosciences Inc (NASDAQ: ANIX) dropped 13.8% to $3.31.
  • Lovesac Co (NASDAQ: LOVE) dropped 11.4% to $10.47. Stifel Nicolaus downgraded Lovesac from Buy to Hold.
  • Phreesia, Inc. (NYSE: PHR) shares fell 10.2% to $25.76 after the company priced 6.75 million share secondary offering at $26 per share.
  • Applied DNA Sciences Inc (NASDAQ: APDN) fell 9.4% to $3.86 after the company reported worse-than-expected Q4 EPS and sales results.
  • Avalon GloboCare Corp. (NASDAQ: AVCO) fell 8.5% to $2.1238.

Posted-In: Mid-Day MoversNews Movers & Shakers Intraday Update Markets Movers Trading Ideas General

 

Related Articles (ADBE + AHCO)

View Comments and Join the Discussion!
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com